ORKA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Oruka Therapeutics, Inc.

NASDAQ | ORKA

27.71

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$1.46B

Market Cap

-

P/E Ratio

-

EPS

$31.00

52 Week High

$5.49

52 Week Low

HEALTHCARE

Sector

ORKA Chart

Recent Chart
Price Action

ORKA Technicals

Tags:

ORKA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$27K
Total Revenue -
Cost Of Revenue $27K
Costof Goods And Services Sold $27K
Operating Income -$88M
Selling General And Administrative -
Research And Development $75M
Operating Expenses $88M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense $1.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $27K
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$82M
Net Income -$84M

Revenue & Profitability

Earnings Performance

ORKA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $396M
Total Current Assets $377M
Cash And Cash Equivalents At Carrying Value $62M
Cash And Short Term Investments $62M
Inventory -
Current Net Receivables -
Total Non Current Assets $19M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $18M
Short Term Investments $314M
Other Current Assets $1.2M
Other Non Current Assets -
Total Liabilities $14M
Total Current Liabilities $13M
Current Accounts Payable $3.5M
Deferred Revenue -
Current Debt -
Short Term Debt $213K
Total Non Current Liabilities $755K
Capital Lease Obligations $968K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $968K
Other Current Liabilities $9.4M
Other Non Current Liabilities -
Total Shareholder Equity $382M
Treasury Stock -
Retained Earnings -$84M
Common Stock $37K
Common Stock Shares Outstanding $17M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (None)
Operating Cashflow -$58M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $27K
Capital Expenditures $189K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$330M
Cashflow From Financing $450M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$84M

yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$27K
Total Revenue -
Cost Of Revenue $27K
Costof Goods And Services Sold $27K
Operating Income -$88M
Selling General And Administrative -
Research And Development $75M
Operating Expenses $88M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense $1.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $27K
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$82M
Net Income -$84M

Dividends

Field Value
Ex Dividend Date 2024-08-29
Declaration Date 2024-08-16
Record Date 2024-08-26
Payment Date 2024-08-28
Amount 1.613

ORKA News

ORKA Profile

Oruka Therapeutics, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Oruka Therapeutics, Inc. is a pioneering biotechnology firm focused on developing innovative therapies for addressing critical medical needs associated with chronic and complex diseases. Leveraging cutting-edge research and development capabilities, the company aims to bring transformative treatment solutions to market. With a diverse pipeline of promising product candidates and a strong emphasis on scientific rigor, Oruka Therapeutics is strategically positioned to enhance patient outcomes significantly while driving substantial value for its investors.

LPTX
+368.57%
$2.05
DRCT
+7.89%
$0.12
PAVS
-94.00%
$0.06
KTTA
+38.67%
$1.47
QTTB
+95.43%
$4.28
KALA
+86.31%
$1.80
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.59%
$179.83
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
FTEL
+54.11%
$1.31
BITF
-6.46%
$3.25
IVP
+1.36%
$0.12
ASST
-6.53%
$1.04
ADAP
-15.14%
$0.05
CHR
+4.33%
$0.04
PLUG
+1.51%
$2.01
INTC
-1.54%
$39.93
SOND
-23.45%
$0.12
BURU
-4.62%
$0.23
RMBL
+60.50%
$3.21
BMNR
-12.19%
$29.08
LNW
-3.71%
$86.22
AAL
+0.12%
$14.06
NFE
+13.11%
$1.38
ADD
-25.47%
$0.05
BIYA
+17.05%
$0.29
AHMA
+140.33%
$11.56
SRM
+53.27%
$10.30
TLRY
-4.69%
$0.77
CNEY
-15.81%
$1.22
BYND
+2.87%
$1.01
RPGL
+2.39%
$0.41
ONDS
-2.91%
$7.67
BMNU
-24.74%
$6.16
IRBT
+15.18%
$1.81
NIO
-5.90%
$5.17
CLSK
-4.02%
$14.49
TSLA
-0.28%
$428.92
YGMZ
+0.17%
$0.11
WLGS
-5.57%
$0.04
SNAP
-0.20%
$7.66
MTSR
-0.35%
$70.50
SOFI
-1.05%
$29.40
F
+0.10%
$13.29
ADTX
+21.01%
$3.80
INHD
-16.59%
$0.18
MARA
-6.26%
$11.07
PFE
-1.24%
$25.41
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
CAN
-6.56%
$0.94
BTG
-1.05%
$4.57
BTBT
-6.72%
$2.22
RIVN
+3.57%
$17.46
CIFR
-2.72%
$19.79
NWTN
-9.09%
$0.70
IREN
-1.32%
$47.81
MSTR
-10.92%
$157.83
GRYP
-10.38%
$1.38
HOOD
-4.68%
$122.47
MODV
-25.22%
$0.43
DNN
0.00%
$2.56
NCT
-29.38%
$0.54
AMZN
+0.55%
$234.51
RIG
+0.80%
$4.44
PLTR
-0.02%
$168.41
AG
+2.79%
$15.65
AMD
+0.47%
$218.57
T
+0.77%
$26.02
AMC
+6.52%
$2.45
RUBI
-12.21%
$0.14
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
GOOGL
-0.82%
$317.54
WULF
-2.40%
$15.13
ACHR
-3.72%
$7.50
EXK
-4.32%
$9.50
DVLT
-4.18%
$1.94
CPNG
-4.33%
$26.93
SAND
-6.04%
$12.12
ITUB
-1.08%
$7.71
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBAN
+1.62%
$16.56
WBUY
+46.66%
$2.31
AAPL
+0.28%
$279.64
IBRX
-1.26%
$2.33
RGTI
-7.45%
$23.66
CRWV
+3.56%
$75.72
CMG
+1.43%
$34.52
HL
+2.29%
$17.20
GPUS
-7.34%
$0.28
MU
+2.70%
$236.48
BAC
-0.15%
$53.56
CDE
-0.31%
$17.21
PLTD
+0.21%
$7.05
APLD
+3.21%
$27.97
LPTX
+368.57%
$2.05
DRCT
+7.89%
$0.12
PAVS
-94.00%
$0.06
KTTA
+38.67%
$1.47
QTTB
+95.43%
$4.28
KALA
+86.31%
$1.80
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.59%
$179.83
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
FTEL
+54.11%
$1.31
BITF
-6.46%
$3.25
IVP
+1.36%
$0.12
ASST
-6.53%
$1.04
ADAP
-15.14%
$0.05
CHR
+4.33%
$0.04
PLUG
+1.51%
$2.01
INTC
-1.54%
$39.93
SOND
-23.45%
$0.12
BURU
-4.62%
$0.23
RMBL
+60.50%
$3.21
BMNR
-12.19%
$29.08
LNW
-3.71%
$86.22
AAL
+0.12%
$14.06
NFE
+13.11%
$1.38
ADD
-25.47%
$0.05
BIYA
+17.05%
$0.29
AHMA
+140.33%
$11.56
SRM
+53.27%
$10.30
TLRY
-4.69%
$0.77
CNEY
-15.81%
$1.22
BYND
+2.87%
$1.01
RPGL
+2.39%
$0.41
ONDS
-2.91%
$7.67
BMNU
-24.74%
$6.16
IRBT
+15.18%
$1.81
NIO
-5.90%
$5.17
CLSK
-4.02%
$14.49
TSLA
-0.28%
$428.92
YGMZ
+0.17%
$0.11
WLGS
-5.57%
$0.04
SNAP
-0.20%
$7.66
MTSR
-0.35%
$70.50
SOFI
-1.05%
$29.40
F
+0.10%
$13.29
ADTX
+21.01%
$3.80
INHD
-16.59%
$0.18
MARA
-6.26%
$11.07
PFE
-1.24%
$25.41
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
CAN
-6.56%
$0.94
BTG
-1.05%
$4.57
BTBT
-6.72%
$2.22
RIVN
+3.57%
$17.46
CIFR
-2.72%
$19.79
NWTN
-9.09%
$0.70
IREN
-1.32%
$47.81
MSTR
-10.92%
$157.83
GRYP
-10.38%
$1.38
HOOD
-4.68%
$122.47
MODV
-25.22%
$0.43
DNN
0.00%
$2.56
NCT
-29.38%
$0.54
AMZN
+0.55%
$234.51
RIG
+0.80%
$4.44
PLTR
-0.02%
$168.41
AG
+2.79%
$15.65
AMD
+0.47%
$218.57
T
+0.77%
$26.02
AMC
+6.52%
$2.45
RUBI
-12.21%
$0.14
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
GOOGL
-0.82%
$317.54
WULF
-2.40%
$15.13
ACHR
-3.72%
$7.50
EXK
-4.32%
$9.50
DVLT
-4.18%
$1.94
CPNG
-4.33%
$26.93
SAND
-6.04%
$12.12
ITUB
-1.08%
$7.71
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBAN
+1.62%
$16.56
WBUY
+46.66%
$2.31
AAPL
+0.28%
$279.64
IBRX
-1.26%
$2.33
RGTI
-7.45%
$23.66
CRWV
+3.56%
$75.72
CMG
+1.43%
$34.52
HL
+2.29%
$17.20
GPUS
-7.34%
$0.28
MU
+2.70%
$236.48
BAC
-0.15%
$53.56
CDE
-0.31%
$17.21
PLTD
+0.21%
$7.05
APLD
+3.21%
$27.97
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.